NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tierra Biosciences

Tierra Biosciences

Private
San Leandro, CaliforniaHealthcare & Life Scienceshttps://www.revr.bio/

Last Round

Series A

Mar 12, 2024

Total Funding Raised

$18.9M

Company Overview

Tierra Biosciences is a biotechnology company that provides a predictive AI-guided, cell-free platform for high-throughput, on-demand custom protein synthesis for customers in the pharmaceutical, agricultural, and industrial sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

cell-free protein synthesiscustom protein synthesisprotein engineeringsynthetic biologybiofoundryautomated protein productiondrug discoverygenerative protein modelsprotein designhigh-throughput screeningbiotech platformassay developmentprotein expressiondigital-to-physical workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tierra Biosciences Comparables

Compare Tierra Biosciences with similar companies based on industry and business-model similarity.

Tierra Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Liberum Biotech
88%
LenioBio
80%
Synthelis Biotech
79%

Tierra Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 12, 2024
SeedSep 12, 2018
GrantMar 1, 2018
GrantJan 1, 2016

Tierra Biosciences Investors

Notable investors and investment history

Tierra Biosciences investors
InvestorRounds
NIH RADxSeries A
Creative VenturesSeries A
Gates FoundationSeries A
Freeflow VenturesSeries A
Material ImpactSeries A
Social CapitalSeries A, Seed
HillspireSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2024

    $7M raised with participation from Material Impact and Hillspire.

Tierra Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tierra Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tierra Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Leandro, California
Employee Range11
Year Founded2015
Last FundingMar 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.